Eganelisib (USAN), codenamed IPI-549, is an experimental drug being investigated as a possible treatment for cancer. It is a highly selective phosphoinositide...
10 KB (801 words) - 03:34, 29 July 2024
non-Coronaviridae Nidovirales. 3CLpro-1 Carmofur COVID Moonshot Ebselen EDP-235 Eganelisib GC376 GRL-0617 Nirmatrelvir Olgotrelvir RAY1216 Rupintrivir SIM0417 Theaflavin...
17 KB (1,651 words) - 07:02, 9 July 2024
of which have been completed or terminated as of March 2022[update]. Eganelisib (codenamed IPI-549; PIK3CD inhibitor) is currently undergoing three phase...
45 KB (5,359 words) - 22:07, 19 July 2024